Abbott has been a world leader in medicine for 130 years, helping people live their lives to the fullest at all stages. We develop new products and technologies in such areas as diagnostics, blood testing, nutrition, production of coronary stents, a wide range of minimally invasive medical devices. We produce medicines that are trusted all over the world, and help patients with diabetes effectively manage the disease.
Abbott is one of the world’s largest diversified healthcare companies. Our 103,000 employees work for the benefit of people in 160 countries. Abbott is one of the first foreign investors in our country, having opened the production of baby food 40 years ago in the USSR.
In 2014 Abbott acquires Veropharm and begins a large-scale modernization of its enterprises, systematically transferring technologies and localizing the production of medicines in Russia. Abbott’s production facilities are represented in Volginsky (Vladimir region), Belgorod and Voronezh. The company employs more than 3,500 people in Russia.
Our company is a strategic investor and contributes to the development of a modern healthcare system. We strive to ensure that high-quality medicines and innovative medical technologies become available to more people in Russia.